Crohn's symptoms and recurring disease flares
Potential benefit studied: Research into active symptoms and prevention of relapse
Supporting researchA randomized human study found that H15 boswellia extract improved Crohn’s disease activity scores.
A randomized study assigned 102 people with active Crohn’s disease to H15 boswellia extract or mesalazine and measured changes in disease activity.
H15 and Boswelan are specific preparations, and neither trial tested Mobility's 100 mg Boswellia at 30% AKBA with moringa. The evidence does not support claiming this product controls Crohn's disease or prevents relapse.
The doses above describe research, not personal dosing instructions. Ingredient studies do not diagnose symptoms or establish medical suitability. Discuss medicines, existing conditions and treatment decisions with an appropriate healthcare professional.